Sprint: DTx and RPM for Oncology

Cancer is a source of significant and growing mortality worldwide. In 2020, it was the therapeutic area with more capital invested in digital health, 12% of venture funding in digital health was focused on oncology companies. Recent results (https://cutt.ly/RjIOIS9 & https://cutt.ly/njIOPM5) show that digital symptom monitoring during chemotherapy can help patients improve quality of life, live longer and reduce hospitalisation and ER visits. But having the results is not enough; identifying the best route to market and overcoming the adoption challenges are key to be successful. Join this series of 2 meetings to discuss in detail with other thought leaders the best routes to market to get paid for a digital health solution in oncology and the challenges in adoption and last-mile distribution.